In this engaging conversation, Brian Pepin, CEO of Rune Labs, shares his visionary work in precision medicine for neurodegenerative diseases. He discusses how Rune Labs is leveraging real-world data to transform therapy development, particularly for Parkinson's. The episode highlights the groundbreaking use of digital biomarkers for tracking disease progression and the innovative StrivePD system that enhances dopamine management via the Apple Watch. Pepin emphasizes patient empowerment through data accessibility and the collaboration needed to reshape healthcare.